Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

329 ARTÍCULOS , VIENDO DEL 196 AL 210

Video prompting versus other instruction strategies for persons with Alzheimer's disease

Perilli V, Lancioni GE, Hoogeveen F, Caffó A, Singh N, O'Reilly M, Sigafoos J, Cassano G, Oliva D.

Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):393-402. doi: 10.1177/1533317513488913. Epub 2013 May 17.

The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: study protocol for a randomized controlled trial

Chiatti C, Masera F, Rimland JM, Cherubini A, Scarpino O, Spazzafumo L, Lattanzio F; UP-TECH research group.

Trials. 2013 May 28;14:155. doi: 10.1186/1745-6215-14-155.

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence

Freiherr J, Hallschmid M, Frey WH 2nd, Brünner YF, Chapman CD, Hölscher C, Craft S, De Felice FG, Benedict C.

CNS Drugs. 2013 Jul;27(7):505-14. doi: 10.1007/s40263-013-0076-8.

The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors

Grossberg GT, Manes F, Allegri RF, Gutiérrez-Robledo LM, Gloger S, Xie L, Jia XD, Pejović V, Miller ML, Perhach JL, Graham SM.

CNS Drugs. 2013 Jun;27(6):469-78. doi: 10.1007/s40263-013-0077-7.

Intravenous immunoglobulin and Alzheimer's disease: what now?

Loeffler DA.

J Neuroinflammation. 2013 Jun 5;10:70. doi: 10.1186/1742-2094-10-70.

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response

Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R.

BMC Geriatr. 2013 Jun 6;13:56. doi: 10.1186/1471-2318-13-56.

Need for and challenges facing functional communication as outcome parameter in AD clinical trials

Haberstroh J, Wollstadt P, Knebel M, Oswald F, Schröder J, Pantel J.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):293-301. doi: 10.1097/WAD.0b013e318299d28d.

Effects of ramelteon on refractory behavioral and psychological symptoms of dementia in Alzheimer disease

Asano M, Ishitobi M, Tanaka Y, Wada Y.

J Clin Psychopharmacol. 2013 Aug;33(4):579-81. doi: 10.1097/JCP.0b013e3182946702.

Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease

Rive B, Gauthier S, Costello S, Marre C, François C.

CNS Drugs. 2013 Jul;27(7):573-82. doi: 10.1007/s40263-013-0074-x.

The benzazole scaffold: a SWAT to combat Alzheimer's disease

Noël S, Cadet S, Gras E, Hureau C.

Chem Soc Rev. 2013 Oct 7;42(19):7747-62. doi: 10.1039/c3cs60086f. Epub 2013 Jun 24.

Understanding placebo responses in Alzheimer's disease clinical trials from the literature meta-data and CAMD database

Ito K, Corrigan B, Romero K, Anziano R, Neville J, Stephenson D, Lalonde R.

J Alzheimers Dis. 2013;37(1):173-83. doi: 10.3233/JAD-130575.

Caregiver outcomes of partners in dementia care: effect of a care coordination program for veterans with dementia and their family members and friends

Bass DM, Judge KS, Snow AL, Wilson NL, Morgan R, Looman WJ, McCarthy CA, Maslow K, Moye JA, Randazzo R, Garcia-Maldonado M, Elbein R, Odenheimer G, Kunik ME.

J Am Geriatr Soc. 2013 Aug;61(8):1377-86. doi: 10.1111/jgs.12362. Epub 2013 Jul 19.

Interprofessional education in community-based Alzheimer's disease diagnosis and treatment

McCaffrey R, Tappen RM, Lichtstein DM, Friedland M.

J Interprof Care. 2013 Nov;27(6):534-6. doi: 10.3109/13561820.2013.817384. Epub 2013 Jul 23.

Learning in Alzheimer's disease is facilitated by social interaction

Duff MC, Gallegos DR, Cohen NJ, Tranel D.

J Comp Neurol. 2013 Dec 15;521(18):4356-69. doi: 10.1002/cne.23433.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias